bufalin has been researched along with Breast Cancer in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, P; Li, Y; Liu, X; Tian, X | 1 |
Gong, P; Kong, C; Li, Y; Tian, X | 1 |
Che, X; Liu, Y; Ma, Y; Qu, X; Teng, Y; Xu, L; Yan, S; Zhang, L; Zou, H | 1 |
Fang, J; Jiang, Y; Liu, Y; Luo, Y; Ma, P; Meng, F; Sui, C; Tian, X; Xu, K; Yin, H; Zhang, S | 1 |
Jia, T; Liu, C; Liu, T; Ni, Z; Sun, J; Wang, X; Xu, J; Yuan, X; Yuan, Y | 1 |
Liu, Y; Qu, X; Song, N; Teng, Y; Xu, C; Xu, L; Yan, S; Zhang, L; Zhu, Z | 1 |
6 other study(ies) available for bufalin and Breast Cancer
Article | Year |
---|---|
Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways.
Topics: Animals; Breast Neoplasms; Bufanolides; Carcinogenesis; Cell Death; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Pore Complex Proteins; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction | 2018 |
Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Bufanolides; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mitochondrial Proteins; Necroptosis; Nuclear Pore Complex Proteins; Phosphoprotein Phosphatases; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; RNA-Binding Proteins; Tumor Cells, Cultured | 2019 |
Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cholesterol; Female; Humans; Membrane Microdomains; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Permeability; Reactive Oxygen Species; Receptors, Growth Factor | 2014 |
Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bufanolides; Cell Survival; Drug Delivery Systems; Drug Liberation; Endocytosis; Female; Flow Cytometry; Humans; Hydrodynamics; MCF-7 Cells; Methacrylates; Mice, Inbred BALB C; Micelles; Octreotide; Particle Size; Polymers; Prodrugs; Receptors, Somatostatin; Tissue Distribution | 2016 |
Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-cbl; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA Interference; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |